Yahoo Web Search

Search results

    • Aptevo Therapeutics Announces Closing of $2.75 Million Offering

      PharmiWeb· 7 days ago

      ...company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today announced the closing of its previously announced offering of (i) 5,339,806 shares of its common stock or pre-funded warrants in lieu thereof and (ii) ...